Antithrombotic therapy for atrial fibrillation and comorbidities — how to choose the optimal solution?
The review discusses the problem of anticoagulant therapy for the prevention of stroke and systemic embolism in patients with atrial fibrillation and comorbidities (hypertension, heart defects, including after heart valve surgery, coronary artery disease, diabetes mellitus, chronic kidney disease, g...
Gespeichert in:
Veröffentlicht in: | Rossiĭskiĭ kardiologicheskiĭ zhurnal 2022-01, Vol.26 (12), p.4801 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The review discusses the problem of anticoagulant therapy for the prevention of stroke and systemic embolism in patients with atrial fibrillation and comorbidities (hypertension, heart defects, including after heart valve surgery, coronary artery disease, diabetes mellitus, chronic kidney disease, gastrointestinal diseases, anemia, cancer), as well as with a high risk of emergency operations and injuries. |
---|---|
ISSN: | 1560-4071 2618-7620 |
DOI: | 10.15829/1560-4071-2021-4801 |